Published Data Show “Significant Improvement” With LAVIV

Pivotal clinical trial data demonstrating the effectiveness of LAVIV (azficel-T) in the treatment of moderate-to-severe nasolabial fold wrinkles has been published by the Dermatologic Surgery journal (online, March 2012). The data includes the combined results of two identically designed, Phase III, multicenter, randomized, double-blind, placebo-controlled studies of 421 patients. The criteria for a positive response included a two-point improvement in the Subject Wrinkle Assessment Scale and a two-point improvement on the Evaluator Wrinkle Assessment Scale for both nasolabial folds.

read more